Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Other Accumulated Expenses (2022 - 2025)

Pediatrix Medical (MD) has disclosed Other Accumulated Expenses for 10 consecutive years, with $51.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 18.39% to $51.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $51.3 million, a 18.39% decrease, with the full-year FY2025 number at $51.3 million, down 18.39% from a year prior.
  • Other Accumulated Expenses was $51.3 million for Q4 2025 at Pediatrix Medical, down from $56.7 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $68.4 million in Q4 2022 to a low of $46.3 million in Q4 2023.
  • A 4-year average of $57.0 million and a median of $57.6 million in 2025 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: tumbled 32.38% in 2023, then soared 35.91% in 2024.
  • Pediatrix Medical's Other Accumulated Expenses stood at $68.4 million in 2022, then crashed by 32.38% to $46.3 million in 2023, then surged by 35.91% to $62.9 million in 2024, then fell by 18.39% to $51.3 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Other Accumulated Expenses are $51.3 million (Q4 2025), $56.7 million (Q3 2025), and $57.6 million (Q2 2025).